The estimated Net Worth of Suzanne Crowe is at least 39.4 千$ dollars as of 20 September 2021. Suzanne Crowe owns over 1,066 units of AVITA Medical Inc stock worth over 39,352$ and over the last 3 years Suzanne sold RCEL stock worth over 0$.
Suzanne has made over 1 trades of the AVITA Medical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Suzanne bought 1,066 units of RCEL stock worth 18,207$ on 20 September 2021.
The largest trade Suzanne's ever made was buying 1,066 units of AVITA Medical Inc stock on 20 September 2021 worth over 18,207$. On average, Suzanne trades about 213 units every 0 days since 2021. As of 20 September 2021 Suzanne still owns at least 4,112 units of AVITA Medical Inc stock.
You can see the complete history of Suzanne Crowe stock trades at the bottom of the page.
Suzanne's mailing address filed with the SEC is C/O AVITA MEDICAL 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355.
Over the last 5 years, insiders at AVITA Medical Inc have traded over 2,850,472$ worth of AVITA Medical Inc stock and bought 19,459 units worth 293,310$ . The most active insiders traders include Michael S Perry、James Corbett、David D O'toole. On average, AVITA Medical Inc executives and independent directors trade stock every 82 days with the average trade being worth of 135,636$. The most recent stock trade was executed by David D O'toole on 30 May 2024, trading 1,000 units of RCEL stock currently worth 8,900$.
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
AVITA Medical Inc executives and other stock owners filed with the SEC include: